Ades, L., Prebet, T., Stamatoullas, A., Recher, C., Guieze, R., Raffoux, E., . . . Fenaux, P. (2017). Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des Myélodysplasies. Haematologica.
Citação norma ChicagoAdes, Lionel, et al. "Lenalidomide Combined With Intensive Chemotherapy in Acute Myeloid Leukemia and Higher-risk Myelodysplastic Syndrome With 5q Deletion. Results of a Phase II Study By the Groupe Francophone Des Myélodysplasies." Haematologica 2017.
Citação norma MLAAdes, Lionel, et al. "Lenalidomide Combined With Intensive Chemotherapy in Acute Myeloid Leukemia and Higher-risk Myelodysplastic Syndrome With 5q Deletion. Results of a Phase II Study By the Groupe Francophone Des Myélodysplasies." Haematologica 2017.